Author: Tom Wilemon
Cancer Center’s annual scientific retreat set for May 1
Apr. 22, 2019—The varying roles that signaling molecules play in progression of cancer is the focus of the Vanderbilt-Ingram Cancer Center 20th Annual Scientific Retreat when some of the nation’s top experts will speak about “Signal Transduction in Cancer Initiation, Progression and Treatment.”
Asian nations in early tobacco epidemic: study
Apr. 18, 2019—Asian countries are in the early stages of a tobacco smoking epidemic with habits mirroring those of the United States from past decades, setting the stage for a spike in future deaths from smoking-related diseases.
Team explores fungal infection quandary in lung cancer screenings
Apr. 18, 2019—Serving a region that lies within the tobacco belt, clinicians at Vanderbilt Health face challenges distinguishing lung cancer from histoplasmosis, a fungal infection that creates cancer-mimicking lesions in the lungs.
Study reframes approach to targeted therapy resistance
Apr. 11, 2019—When a tumor mutates and develops resistance to a targeted therapy, researchers often focus on the acquisition of new mutations within the drug target as they seek an alternative treatment, but a team of Vanderbilt scientists has shown this may not be sufficient.
Head and neck cancer screening event set for April 12
Apr. 4, 2019—Early diagnosis of head and neck cancer greatly increases odds of survival, but its symptoms can be subtle or mimic viral infections, so Vanderbilt Health offers a free screening annually.
Hot chemotherapy surgery helps save patient’s leg
Mar. 28, 2019—Tom Deweese can keep up with his grandchildren because of a highly specialized surgery using hot chemotherapy that saved his leg.
Cancer Center Ambassadors surpass $1 million in grants
Mar. 14, 2019—Vanderbilt-Ingram Cancer Center Ambassadors surpassed the $1 million mark with the awarding of the group’s latest research grants.
Investigators map genomic landscape of very rare cancer
Feb. 28, 2019—A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.
VICC launches new telehealth program for CAR-T patients
Feb. 28, 2019—Some cancer patients receiving CAR-T infusions can now avoid hospital stays because of a telemedicine program launched by Vanderbilt-Ingram Cancer Center.
AHA statement supports vascular cardio-oncology
Feb. 21, 2019—The American Heart Association (AHA) has issued a scientific statement calling for the integration of cardio-oncology and vascular medicine to provide cancer patients and cancer survivors with optimal cardiovascular care.
Grant supports novel imaging initiative to enhance cancer care
Jan. 31, 2019—A Vanderbilt initiative to develop predictive imaging technologies that clinicians can use to better match patients with personalized care has received National Cancer Institute (NCI) funding.
Study identifies novel genetic factors for colorectal cancer risk
Jan. 10, 2019—A large-scale study conducted among East Asians and led by Vanderbilt researchers has identified multiple, previously unknown genetic risk factors for colorectal cancer.
